Literature DB >> 23928876

Hyperleptinemia: implications on the inflammatory state and vascular protection in obese adolescents submitted to an interdisciplinary therapy.

Priscila L Sanches1, Marco T de Mello, Natália Elias, Francisco A H Fonseca, Raquel M S Campos, June Carnier, Aline de Piano, Deborah C L Masquio, Patrícia L Silva, Lila M Oyama, Flavia C Corgosinho, Cláudia M O Nascimento, Lian Tock, Carolina Ackel D'Elia, Sergio Tufik, Ana R Dâmaso.   

Abstract

The low-grade systemic inflammation seen in obesity may affect the actions of some adipose tissue-derived adipokines that are involved in the regulation of vascular function. We sought to verify whether hyperleptinemia may influence the inflammatory and atherogenic responses in obese adolescents undergoing interdisciplinary therapy. Thirty-four obese adolescents underwent interdisciplinary therapy for 1 year. Subjects were considered hyperleptinemic if they had baseline values of leptin above 20 ng/mL for boys and 24 ng/mL for girls. Both groups showed an improvement in body composition and a reduction in carotid intima-media thickness. However, only subjects in the non-hyperleptinemic group showed an increase in adiponectin concentration after therapy. Moreover, leptin concentration was positively correlated with adiponectin and inversely correlated with PAI-1 in this group. Hyperleptinemic state may impair the attenuation of inflammation in obese adolescents undergoing interdisciplinary therapy, particularly by impeding the increase in adiponectin concentration, which is directly involved in vascular protection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23928876     DOI: 10.1007/s10753-013-9709-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  36 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss.

Authors:  Ana R Dâmaso; Aline de Piano; Priscila L Sanches; Flávia Corgosinho; Lian Tock; Lila M Oyama; Luciana Tock; Claudia M Oller do Nascimento; Sérgio Tufik; Marco Túlio de Mello
Journal:  Peptides       Date:  2011-05-06       Impact factor: 3.750

Review 3.  Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease.

Authors:  Yuji Matsuzawa
Journal:  Atheroscler Suppl       Date:  2005-05       Impact factor: 3.235

Review 4.  Leptin and the regulation of endothelial function in physiological and pathological conditions.

Authors:  Jerzy Bełtowski
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-02       Impact factor: 2.557

5.  Inflammatory markers and metabolic syndrome among adolescents.

Authors:  M González; M del Mar Bibiloni; A Pons; I Llompart; J A Tur
Journal:  Eur J Clin Nutr       Date:  2012-08-22       Impact factor: 4.016

Review 6.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

7.  Leptin-induced endothelial dysfunction in obesity.

Authors:  Mykhaylo Korda; Ruslan Kubant; Stephen Patton; Tadeusz Malinski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-08       Impact factor: 4.733

8.  The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.

Authors:  Zaira Quijada; Mariela Paoli; Yajaira Zerpa; Nolis Camacho; Rosanna Cichetti; Vanessa Villarroel; Gabriela Arata-Bellabarba; Roberto Lanes
Journal:  Pediatr Diabetes       Date:  2008-05-23       Impact factor: 4.866

9.  Determinants of early atherosclerosis in obese children and adolescents.

Authors:  Véronique Beauloye; Francis Zech; Hiep Thi Mong Tran; Philippe Clapuyt; Marc Maes; Sonia M Brichard
Journal:  J Clin Endocrinol Metab       Date:  2007-05-22       Impact factor: 5.958

10.  Carotid intima-media thickness in pediatric type 1 diabetic patients.

Authors:  Rocio Rabago Rodriguez; Rita A Gómez-Díaz; Janet Tanus Haj; Francisco Jose Avelar Garnica; Eleazar Ramirez Soriano; Elisa Nishimura Meguro; Carlos A Aguilar-Salinas; Niels H Wacher
Journal:  Diabetes Care       Date:  2007-07-20       Impact factor: 19.112

View more
  6 in total

1.  Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.

Authors:  Farah N Ali; Bonita Falkner; Samuel S Gidding; Heather E Price; Scott W Keith; Craig B Langman
Journal:  J Pediatr       Date:  2014-07-22       Impact factor: 4.406

2.  Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males.

Authors:  Bonita Falkner; Scott W Keith; Samuel S Gidding; Craig B Langman
Journal:  J Am Soc Hypertens       Date:  2017-04-12

3.  Benefits of Regular Exercise on Inflammatory and Cardiovascular Risk Markers in Normal Weight, Overweight and Obese Adults.

Authors:  Olivia Santos Gondim; Vinicius Tadeu Nunes de Camargo; Fernanda Almeida Gutierrez; Patricia Fátima de Oliveira Martins; Maria Elizabeth Pereira Passos; Cesar Miguel Momesso; Vinicius Coneglian Santos; Renata Gorjão; Tania Cristina Pithon-Curi; Maria Fernanda Cury-Boaventura
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

4.  Different metabolic responses induced by long-term interdisciplinary therapy in obese adolescents related to ACE I/D polymorphism.

Authors:  Sandro S Almeida; Flavia C Corgosinho; Carlos En Amorim; Marcos F Gregnani; Raquel Ms Campos; Deborah Cl Masquio; Priscila L Sanches; Aline P Ganen; João B Pesquero; Ana R Dâmaso; Marco T Mello; Sergio Tufik; Ronaldo C Araújo
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Apr-Jun       Impact factor: 1.636

5.  Semi-intensive and Intensive Interdisciplinary Treatments Have Similar Effects on Metabolic Syndrome and Selected Inflammatory Markers in Adolescents with Obesity.

Authors:  Luzia Jaeger Hintze; Ana Claudia Pelissari Kravchychyn; Yasmin Alaby Martins Ferreira; Raquel Munhoz da Silveira Campos; Alexandre D Aguilera Dantas; Deborah Cristina Landi Masquio; Danielle Arisa Caranti; David Thivel; Ana R Dâmaso
Journal:  J Obes Metab Syndr       Date:  2021-12-30

Review 6.  Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells.

Authors:  Priya Raman; Saugat Khanal
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.